# Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU

> **NCT04354467** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 148 (actual)

## Conditions studied

- Acute Kidney Injury
- Nephrotoxicity
- Neonatal

## Interventions

- **DIAGNOSTIC_TEST:** urine neutrophil gelatinase -associated lipocalin

## Key facts

- **NCT ID:** NCT04354467
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-28
- **Primary completion:** 2020-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354467, "Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04354467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*